Ying M Tang

US Patent:

7354584, Apr 8, 2008

Filed:

Apr 12, 2004

Appl. No.:

10/823253

Inventors:

Jennifer Lynne Reed - Clarksburg MD, US
Herren Wu - Boyds MD, US
Ying Tang - San Diego CA, US
Julian Davies - San Diego CA, US
Jeffry D. Watkins - Encinitas CA, US

Assignee:

MedImmune, Inc. - Gaithersburg MD

International Classification:

A61K 39/395
G01N 33/53

US Classification:

4241451, 4241331, 5303913, 5303873, 53038823

Abstract:

The present invention provides novel antibodies that immunospecifically bind to an IL-9 polypeptide and compositions comprising said antibodies. The present invention also provides methods and compositions preventing, treating, managing, and/or ameliorating diseases and disorders associated with aberrant expression and/or activity of IL 9 or IL-9 receptor or subunits thereof, autoimmune diseases, inflammatory diseases, proliferative diseases, and infections comprising administration of one or more antibodies thereof that immunospecifically bind to an IL-9 polypeptide. The invention also encompasses methods and compositions for diagnosing, monitoring, and prognosing these disorders. The present invention further relates to articles of manufacture and kits comprising antibodies that immunospecifically bind to an IL-9 polypeptide.

US Patent:

8481037, Jul 9, 2013

Filed:

Jan 14, 2011

Appl. No.:

13/007211

Inventors:

Jennifer Lynne Reed - Clarksburg MD, US
Herren Wu - Boyds MD, US
Ying Tang - San Diego CA, US
Julian Davies - San Diego CA, US
Jeffry Watkins - Encinitas CA, US

Assignee:

MedImmune, LLC - Gaithersburg MD

International Classification:

A61K 39/395

US Classification:

4241451, 4241781

Abstract:

The present invention provides novel antibodies that immunospecifically bind to an IL-9 polypeptide and compositions comprising said antibodies. The present invention also provides methods and compositions preventing, treating, managing, and/or ameliorating diseases and disorders associated with aberrant expression and/or activity of IL 9 or IL-9 receptor or subunits thereof, autoimmune diseases, inflammatory diseases, proliferative diseases, and infections comprising administration of one or more antibodies thereof that immunospecifically bind to an IL-9 polypeptide. The invention also encompasses methods and compositions for diagnosing, monitoring, and prognosing these disorders. The present invention further relates to articles of manufacture and kits comprising antibodies that immunospecifically bind to an IL-9 polypeptide.

US Patent:

20090047277, Feb 19, 2009

Filed:

Jun 27, 2007

Appl. No.:

11/769326

Inventors:

Jennifer Lynne REED - Clarksburg MD, US
Herren Wu - Boyds MD, US
Ying Tang - San Diego CA, US
Julian Davies - San Diego CA, US
Jeffry D. Watkins - Encinitas CA, US

Assignee:

MEDIMMUNE, INC. - Gaithersburg MD

International Classification:

A61K 39/395
C07K 16/18
G01N 33/53
A61P 43/00

US Classification:

4241331, 5303873, 5303913, 5303917, 435 71

Abstract:

The present invention provides novel antibodies that immunospecifically bind to an IL-9 polypeptide and compositions comprising said antibodies. The present invention also provides methods and compositions preventing, treating, managing, and/or ameliorating diseases and disorders associated with aberrant expression and/or activity of IL 9 or IL-9 receptor or subunits thereof, autoimmune diseases, inflammatory diseases, proliferative diseases, and infections comprising administration of one or more antibodies thereof that immunospecifically bind to an IL-9 polypeptide. The invention also encompasses methods and compositions for diagnosing, monitoring, and prognosing these disorders. The present invention further relates to articles of manufacture and kits comprising antibodies that immunospecifically bind to an IL-9 polypeptide.

US Patent:

20100005857, Jan 14, 2010

Filed:

Apr 27, 2007

Appl. No.:

11/796741

Inventors:

Hong Zhang - Metuchen NJ, US
Ying Tang - Glassboro NJ, US
Patricia Mosto - Pitman NJ, US
Courtney E. Richmond - Glassboro NJ, US

Assignee:

Rowan University - Glassboro NJ

International Classification:

G01C 13/00
G01W 1/14
G01N 19/10
B01J 19/00
G01R 29/00

US Classification:

73 2902, 7317029, 7317017, 422 681, 324722

Abstract:

An Interactive Mobile Aquatic Probing and Surveillance system. The system includes a remote aquatic or amphibious agent which is controlled by a typically land-based computer host. The agent is a field robot in the form of a comparatively small and inexpensive, untethered, self-propelled, aquatic or amphibious, non-submersible vehicle that preferably carries physical and water characteristic sensors, as well as other operational equipment for use on relatively small bodies of water and wetlands. The host interacts with a human operator and provides control commands to and receives data from the agent in real time via a wireless communication between the agent and the host. The control commands include guidance commands including navigational and propulsion commands as well as commands for operating the sensors and various other equipment carried by the agent.

US Patent:

20130273071, Oct 17, 2013

Filed:

Jun 6, 2013

Appl. No.:

13/911238

Inventors:

Herren Wu - Gaithersburg MD, US
Ying Tang - San Diego CA, US
Julian Davies - San Diego CA, US
Jeffry Watkins - Encinitas CA, US

International Classification:

C07K 16/24
A61K 45/06
G01N 33/68
A61K 39/395

US Classification:

4241581, 5303892, 5303873, 5303913, 5303917, 436501

Abstract:

The present invention provides novel antibodies that immunospecifically bind to an IL-9 polypeptide and compositions comprising said antibodies. The present invention also provides methods and compositions preventing, treating, managing, and/or ameliorating diseases and disorders associated with aberrant expression and/or activity of IL 9 or IL-9 receptor or subunits thereof, autoimmune diseases, inflammatory diseases, proliferative diseases, and infections comprising administration of one or more antibodies thereof that immunospecifically bind to an IL-9 polypeptide. The invention also encompasses methods and compositions for diagnosing, monitoring, and prognosing these disorders. The present invention further relates to articles of manufacture and kits comprising antibodies that immunospecifically bind to an IL-9 polypeptide.